Fortuneavere Pharmaceuticals Private Limited
About Fortuneavere Pharmaceuticals Private Limited
Data last updated:
Fortuneavere Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74900UP2012PTC053810. Its GSTIN is 09AACCF0912D1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Richa Misra and Kshama Misra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4/59 Vivek Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.2 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹2.91 Lakh (net margin -2.4%) and EBITDA of -₹2.45 Lakh (EBITDA margin -2%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹9 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fortuneavere Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4/59 Vivek Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Fortuneavere Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fortuneavere Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Fortuneavere Pharmaceuticals Private Limited, buy the company report.
Financials of Fortuneavere Pharmaceuticals Private Limited
FY 2025 filings availableFortuneavere Pharmaceuticals Private Limited reported revenue of ₹1.2 Cr (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 17% fall in the latest year. EBITDA fell 980% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | ||||
| Net Profit Margin | -2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fortuneavere Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fortuneavere Pharmaceuticals Private Limited
Fortuneavere Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Richa Misra | Director | 27 Nov 2012 | 13 Years 10 Months | Current |
| Kshama Misra | Director | 01 Jun 2020 | 6 Years 4 Months | Current |
| Sanjay Misra | Director | 27 Nov 2012 | 13 Years 10 Months | Current |
Auditor
Fortuneavere Pharmaceuticals Private Limited is audited by SHUKLA MISHRA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHUKLA MISHRA & CO | FY 2022 | 013696C |
Shareholding
The shareholding of Fortuneavere Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fortuneavere Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2013 | 10444287 | Uco Bank | ₹9 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Fortuneavere Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fortuneavere Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fortuneavere Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCF0912D1Z6 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fortuneavere Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fortuneavere Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Kshama Misra was appointed as Director on 01 Jun 2020.
Frequently asked questions
Fortuneavere Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 November 2012 (14+ years old) and is registered under CIN U74900UP2012PTC053810.
Fortuneavere Pharmaceuticals has 3 current directors:
- Richa Misra - Director
- Kshama Misra - Director
- Sanjay Misra - Director
The latest financial statements of Fortuneavere Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Fortuneavere Pharmaceuticals is 09AACCF0912D1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Fortuneavere Pharmaceuticals is U74900UP2012PTC053810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fortuneavere Pharmaceuticals was incorporated on 27 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Kshama Misra was appointed as Director on 01 Jun 2020. Alok Shanker Tewari ceased to be Director on 20 Feb 2017. Richa Misra was appointed as Director on 27 Nov 2012. Fortuneavere Pharmaceuticals has 4 board changes on record in total.
The registered office of Fortuneavere Pharmaceuticals is at 459 Vivek Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Fortuneavere Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Fortuneavere Pharmaceuticals has open charges of ₹9 Lakh and no satisfied charges on record as per latest MCA filings.